Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Rosetta Therapeutics
company
About
Rosetta Therapeutics is a developer of new molecular matter as leads for the cure of neurodegenerative diseases.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Rosetta Therapeutics is an innovative drug discovery start up that offers solutions by providing new validated molecules and high throughput assays, which mitigate risk and lowers costs for Pharma and provides potential cures for human diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Rosetta Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Nov 12, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 12, 2020 | Grant | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Rosetta Therapeutics is funded by 1 investors.
Genome Canada
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Genome Canada
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
